Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering

被引:309
作者
Chung, Hyun Jung [1 ]
Park, Tae Gwan [1 ]
机构
[1] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea
关键词
scaffolds; porous; biomimetic; surface modification; drug delivery; tissue regeneration;
D O I
10.1016/j.addr.2007.03.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A wide range of polymeric scaffolds have been intensively studied for use as implantable and temporal devices in tissue engineering. Biodegradable and biocompatible scaffolds having a highly open porous structure and good mechanical strength are needed to provide an optimal microenvironment for cell proliferation, migration, and differentiation, and guidance for cellular in-growth from host tissue. A variety of natural and synthetic polymeric scaffolds can be :fabricated in the form of a solid foam, nanofibrous matrix, microsphere, or hydrogel. Biodegradable porous scaffolds can be surface engineered to provide an extracellular matrix mimicking environment for better cell adhesion and tissue in-growth. Furthermore, scaffolds can be designed to :release bioactive molecules, such as growth factors, DNA, or drugs, in a sustained manner to facilitate tissue regeneration. This paper reviews the current status of surface engineered and drug releasing scaffolds for tissue engineering. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:249 / 262
页数:14
相关论文
共 140 条
[91]   Perfusion culture of hepatocytes within galactose-derivatized biodegradable poly(lactide-co-glycolide) scaffolds prepared by gas foaming of effervescent salts [J].
Park, TG .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 59 (01) :127-135
[92]  
Park YJ, 2000, BIOMATERIALS, V21, P153
[93]   Cultured chondrocytes produce injectable tissue-engineered cartilage in hydrogel polymer [J].
Passaretti, D ;
Silverman, RP ;
Huang, W ;
Kirchhoff, CH ;
Ashiku, S ;
Randolph, MA ;
Yaremchuk, MJ .
TISSUE ENGINEERING, 2001, 7 (06) :805-815
[94]   Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres [J].
Perets, A ;
Baruch, Y ;
Weisbuch, F ;
Shoshany, G ;
Neufeld, G ;
Cohen, S .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2003, 65A (04) :489-497
[95]  
Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO
[96]  
2-T
[97]   Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats [J].
Pieper, JS ;
Hafmans, T ;
van Wachem, PB ;
van Luyn, MJA ;
Brouwer, LA ;
Veerkamp, JH ;
van Kuppevelt, TH .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 62 (02) :185-194
[98]   Structural specificity of heparin binding in the fibroblast growth factor family of proteins [J].
Raman, R ;
Venkataraman, G ;
Ernst, S ;
Sasisekharan, V ;
Sasisekharan, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2357-2362
[99]  
Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO
[100]  
2-C